Skip to main content
Clinical Trials/NCT02941835
NCT02941835
Terminated
Not Applicable

Preoperative Breast Irradiation, the PROBI Trial. A Phase I/II Feasibility Trial

The Netherlands Cancer Institute1 site in 1 country4 target enrollmentMarch 12, 2018
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
The Netherlands Cancer Institute
Enrollment
4
Locations
1
Primary Endpoint
Postoperative surgical complications
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

The PROBI is a phase I/II trial assessing the feasibility of preoperative whole breast irradiation in female patients with low to intermediate risk breast cancer, who undergo breast conserving therapy, including a boost dose of irradiation.

An additional goal of this study is to assess tumor response to radiotherapy, by imaging modalities (PET-CT and MRI) and pathology

Registry
clinicaltrials.gov
Start Date
March 12, 2018
End Date
August 9, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Histologically proven invasive breast carcinoma
  • cT1-2N0 breast cancer
  • female patients ≤ 50 years
  • planned breast conserving surgery
  • ability to undergo irradiation and surgery
  • signed written informed consent

Exclusion Criteria

  • prior surgery or radiotherapy for the protocol tumor (neoadjuvant chemotherapy or endocrine therapy is allowed)
  • planned oncoplastic reduction mammoplasty
  • extensive calcifications on mammagram (Birads 3,4 or 5)
  • cT3-4 and/or cN1-3 invasive carcinoma
  • distant metastasis

Outcomes

Primary Outcomes

Postoperative surgical complications

Time Frame: within six weeks after surgery

postoperative complication will be scored by a specific list

Secondary Outcomes

  • Radiological response(6 weeks post-radiation)
  • Pathological response(at surgery)
  • cosmetic outcome(1,3 and 5 years post-treatment)

Study Sites (1)

Loading locations...

Similar Trials